2016
DOI: 10.1016/j.jacc.2016.04.024
|View full text |Cite
|
Sign up to set email alerts
|

Idiopathic Restrictive Cardiomyopathy Is Primarily a Genetic Disease

Abstract: performed in patients who received reduced dose NOAC, there were no observed strokes or systemic embolic events in NOAC-treated patients and the bleeding risk was comparable with warfarin. The principle limitation of our study pertains to the observational nature of this analysis, which limits our ability to draw any causal inferences because of residual unmeasured confounding. In addition, we rely on billing codes for patient characteristics and outcome adjudication. As such, we lack clinical characteristics,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
36
0
3

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 61 publications
(42 citation statements)
references
References 5 publications
3
36
0
3
Order By: Relevance
“…Furthermore, a large subgroup of RCM cases manifesting in childhood have an extremely poor prognosis due to underlying metabolic defects (Lee et al, 2017;Papadopoulou-Legbelou, Gogou, & Evangeliou, 2017;Russo & Webber, 2005). Recent advances in genetic sequencing technology have facilitated the identification of mutations causing early-onset RCM and highlighted the involvement of genes encoding contractile and structural proteins (Gallego-Delgado et al, 2016;Kaski et al, 2008;Kostareva et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, a large subgroup of RCM cases manifesting in childhood have an extremely poor prognosis due to underlying metabolic defects (Lee et al, 2017;Papadopoulou-Legbelou, Gogou, & Evangeliou, 2017;Russo & Webber, 2005). Recent advances in genetic sequencing technology have facilitated the identification of mutations causing early-onset RCM and highlighted the involvement of genes encoding contractile and structural proteins (Gallego-Delgado et al, 2016;Kaski et al, 2008;Kostareva et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…To date, dominant pathogenic variants causing RCM have been reported in DES , ACTC1 , TNNI3 , TNNT2 , TPM1 , MYL3 , MYL , MYPN , TTN , BAG3 , FLNC , TTR , and MYH7 , but the majority of cases are considered idiopathic (Towbin, ). However, recent studies of idiopathic RCM cohorts tested using panels of 100–200 CM‐related genes show some success in identifying additional likely pathogenic variants in genes including: DES , LAMP2 , LMNA , BAG3 , JUP , TTN , and others, with 50%–60% of patients having an identified potentially pathogenic variant (Gallego‐Delgado et al., ; Kostareva et al., ). Although previous reports indicate yields of clinical genetic testing around 20% for RCM (Ackerman et al., ), data are limited.…”
Section: Introductionmentioning
confidence: 99%
“…The power and efficiency of WES is demonstrated in the identification of the FLNC mutation in this family, and other pathogenic genes in other RCM pedigrees [8,11,28] , dilated cardiomyopathy [37] , and in disease-gene discovery in general [38] . Although there are commercially available panels to test for mutations in known cardiomyopathy genes, WES is an unbiased search for such mutations and has the power to identify new cardiomyopathy genes.…”
Section: Discussionmentioning
confidence: 92%
“…Typically, these genes encode proteins of the sarcomere, z-disk domain, intermediate filaments, ion channel, intercalated disk, and cytoskeletal proteins [3,[7][8][9][10] . This variable expressivity in cardiomyopathy is seen even within the same family, with multiple diagnoses (including this family and other examples) [7,9,11,12] . RCM can also occur from infiltrative processes, such as amyloid or desmin deposition, often due to genetic mutations.…”
Section: Introductionmentioning
confidence: 79%